Atlas Trials

Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC

Clinical trial NCT01913067 · WITHDRAWN

Trial details

NCT number
NCT01913067
Sponsor
Jules Bordet Institute
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Brain MetastasisBreast CancerNon Small Cell Lung Cancer
Start date
2013-09-01
Primary completion
2016-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.